| 注册
首页|期刊导航|中国临床药理学与治疗学|双PI3K/mTOR抑制剂NVPBEZ235对宫颈癌Hela细胞的放射增敏作用

双PI3K/mTOR抑制剂NVPBEZ235对宫颈癌Hela细胞的放射增敏作用

郑迎奥 李胜泽 张雷 郭祥瑞 鲍佳茜 吴涛 刘健

中国临床药理学与治疗学2018,Vol.23Issue(1):18-23,6.
中国临床药理学与治疗学2018,Vol.23Issue(1):18-23,6.DOI:10.12092/j.issn.1009-2501.2018.01.004

双PI3K/mTOR抑制剂NVPBEZ235对宫颈癌Hela细胞的放射增敏作用

Radio sensitizing effect of double PI3K/mTOR inhibitor NVPBEZ235 on Hela cells of cervical cancer

郑迎奥 1李胜泽 1张雷 2郭祥瑞 3鲍佳茜 4吴涛 4刘健1

作者信息

  • 1. 蚌埠医学院第一附属医院肿瘤妇科,蚌埠233004,安徽
  • 2. 蚌埠医学院第一附属医院肿瘤放疗科,蚌埠233004,安徽
  • 3. 蚌埠医学院第一附属医院妇产科,蚌埠233004,安徽
  • 4. 蚌埠医学院生物科学系,蚌埠233000,安徽
  • 折叠

摘要

Abstract

AIM:To investigate the effect that external irradiation of dual PI3K/mTOR inhibitors NVPBEZ235 on cervical cancer Hela cells.METHODS:Cervical cancer Hela cells treated with different concentrations of NVPBEZ235 and the radiotherapy (irradiation,IR) were examined for cell viability using MTT assay and colony forming ability.The cycle arrest of cervical cancer cells combined drug with IR was analyzed by using the flow cytometry.RESULTS:Compared with the control group,NVPBEZ235 can inhibit human cervical carcinoma cell in vitro (P < 0.05).The combined use of NVPBEZ235 significantly enhanced the inhibitory effect of IR (P<0.05) in Hela cells.In vitro,NVPBEZ235 and IR,which had synergistic effect,can block cell cycle to G2/M period by the combined effect which was significantly greater than the effect of one single drug (P < 0.05).CONCLUSION:20% IC50 NVPBEZ235 can promote the cell's radiation sensitivity,inhibit the proliferation of cells,and thereby,increase its radio sensitivity to cervical cancer cells.

关键词

双PI3 K/mTOR抑制剂/NVPBEZ235/Hela/放射增敏

Key words

dual PI3K/mTOR inhibitor/NVPBEZ235/Hela/radio sensitization

分类

医药卫生

引用本文复制引用

郑迎奥,李胜泽,张雷,郭祥瑞,鲍佳茜,吴涛,刘健..双PI3K/mTOR抑制剂NVPBEZ235对宫颈癌Hela细胞的放射增敏作用[J].中国临床药理学与治疗学,2018,23(1):18-23,6.

基金项目

安徽省教育厅自然科学基金(KJ2015B041,KJ2015B096) (KJ2015B041,KJ2015B096)

大学生创业创新项目(19262,201610367002) (19262,201610367002)

中国临床药理学与治疗学

OACSCDCSTPCD

1009-2501

访问量0
|
下载量0
段落导航相关论文